Sce&Tech
0
plusresetminus
Publish date25 Aug 2013 - 10:43
Story Code : 138953

Iran builds neo-combined drug for child leukemia

Iranian researchers have built a locally-made new medicine dubbed 'L-asparaginase' for treatment of child leukemia, which can be used a neo-combined product, said Head of Biologic Center of Shiraz Medical Sciences University Younes Qasemi.
Iran builds neo-combined drug for child leukemia
The drug was formerly made only by Germany, while it is now given to the patients as a neo-combined drug, he said, adding, the clinical production of the drug has been over.

Access to the technology, gene transfer and purification of protein are of great importance for the process.

The researchers separated L-asparaginase-producing bacteria after the screening process and then the L-asparaginase gene was transferred to bacteria. The purification process was later conducted on the enzyme.

HK
https://taghribnews.com/vdciwvazpt1ap32.ilct.html
Related News
Post a comment
Your Name
Your Email Address
Security Code